PMC:7696151 / 35891-36013 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1040","span":{"begin":60,"end":68},"obj":"Species"},{"id":"1050","span":{"begin":82,"end":85},"obj":"Chemical"}],"attributes":[{"id":"A1040","pred":"tao:has_database_id","subj":"1040","obj":"Tax:9606"},{"id":"A1050","pred":"tao:has_database_id","subj":"1050","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Furthermore, the onset of side effects was more frequent in patients treated with HCQ than placebo (40.1% vs. 16.8%) [41]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T236","span":{"begin":0,"end":122},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Furthermore, the onset of side effects was more frequent in patients treated with HCQ than placebo (40.1% vs. 16.8%) [41]."}